Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-21 | 2023-08-18 | 199554 |
| TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-03-25 | 2021-04-21 | 136341 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-11 | 1760 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-03-18 | 2021-04-21 | 135980 |
| TEVA-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-05-30 | 2025-08-14 | 259023 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-13 | 2017-10-10 | 1778 |
| TEVA-QUININE | 200MG | CAPSULE | Resolved | 2021-12-17 | 2022-01-20 | 151462 |
| TEVA-QUININE | 200MG | CAPSULE | Resolved | 2025-09-25 | 2025-10-30 | 267850 |
| TEVA-QUININE | 200MG | CAPSULE | Resolved | 2020-05-01 | 2020-06-18 | 113735 |
| TEVA-QUININE | 200MG | CAPSULE | Resolved | 2022-06-16 | 2022-12-08 | 162867 |
| TEVA-QUININE | 300MG | CAPSULE | Resolved | 2022-06-16 | 2022-12-08 | 162864 |
| TEVA-QUININE | 300MG | CAPSULE | Resolved | 2019-10-03 | 2020-01-24 | 95393 |
| TEVA-QUININE | 300MG | CAPSULE | Resolved | 2020-05-29 | 2020-07-23 | 116168 |
| TEVA-QUININE | 300MG | CAPSULE | Resolved | 2025-06-13 | 2025-10-30 | 260245 |
| TEVA-QUININE | 300MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-05 | 131072 |
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-03-17 | 2017-10-11 | 3133 |
| TEVA-RABEPRAZOLE EC | 10MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-02-21 | 2020-07-10 | 106939 |
| TEVA-RABEPRAZOLE EC | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-02-07 | 2020-07-10 | 105593 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-03-11 | 2021-03-25 | 135567 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-03-11 | 2021-03-18 | 135570 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |